Related Experiment Videos
HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases
Necati Yenice1, Fatih Güllük, Nurten Arican
1Department of Internal Medicine 3rd Section, SSK Okmeydani Training Hospital, Istanbul, Turkey. netyayincilik@turk.net
Insights
Hepatitis C virus (HCV) is linked to B-cell non-Hodgkin lymphoma, but not Hodgkin lymphoma. This study found higher HCV positivity in B-cell non-Hodgkin lymphoma patients compared to controls.
Area of Science:
- Virology
- Oncology
- Hematology
Background:
- Hepatitis C virus (HCV) infection is a global health concern.
- Lymphoproliferative diseases encompass a range of B-cell malignancies.
- The etiological link between HCV and specific lymphomas requires further investigation.
Purpose of the Study:
- To investigate the association between hepatitis C virus (HCV) infection and B-cell lymphoproliferative diseases.
- To determine if HCV positivity differs between patients with B-cell non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) compared to a healthy control group.
Main Methods:
- Case-control study design.
- Inclusion of 84 B-cell NHL patients, 50 HL patients, and 100 healthy blood donors.
- HCV antibody testing (anti-HCV) performed on all participants.
Main Results:
- Anti-HCV positivity was significantly higher in B-cell NHL patients (7.1%) versus controls (1%, p<0.05).
- Anti-HCV positivity in HL patients (2%) was comparable to the control group (1%, p<0.05).
Conclusions:
- Hepatitis C virus (HCV) may contribute to the pathogenesis of B-cell non-Hodgkin lymphoma.
- The findings do not support a role for HCV in the development of Hodgkin lymphoma.
Background/Aims:
In this study we aimed to investigate the relation between hepatitis C virus (HCV) and B cell lymphoproliferative diseases.
Methods:
Eighty-four patients with B-cell non-Hodgkin lymphoma and 50 patients with Hodgkin lymphoma were included. Control group consisted of another 100 otherwise healthy blood donors who had no previous history of invasive surgery, blood transfusions, and viral hepatitis. HCV positivity was investigated in both case groups and control group.
Results:
Anti-HCV positivity was significantly more frequent in B-cell non-Hodgkin lymphoma patients compared to control group (7.1% vs. 1%, p<0.05). In Hodgkin lymphoma patients however, frequency was comparable with the control group (2% vs. 1%, p<0.05).
Conclusions:
These findings suggest that HCV may play a role in the development of B-cell non-Hodgkin lymphoma, but not in Hodgkin lymphoma.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Cytomegalovirus Disease
Genital Herpes